How to spark the interest of VCs for Series A financing?
Bart Wuurman is an accomplished biotech CEO with strong experience in biotech start-up financing, strategic leadership, product development and Business Development & Licensing.
As biotech entrepreneur and executive, he was instrumental to the profitable exits of three biotech companies: Lanthio Pharma, AM-Pharma and Antisoma. He is passionate about bringing strategic focus and establishing a balanced team of experienced executives to execute the optimal value creating strategy.
During 26 years with innovative R&D based life sciences companies, Bart has built a broad experience in pharmaceutical product discovery and development, in many therapeutic areas, including cancer, critical care and fibrosis.
Bart holds non-executive director positions in several companies.